NEW INSIGHTS INTO THE PATHOGENESIS AND TREATMENT ADVANCES OF AGE - RELATED MACULAR DEGENERATION

Area of Science:

• Ophthalmology
• Genetics
• Cell Biology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
• Understanding AMD pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

• To review the latest advancements in AMD pathogenesis.
• To highlight significant progress in AMD treatment strategies.

Main Methods:

• Comprehensive literature review of recent studies on AMD.
• Analysis of genetic, environmental, and metabolic factors in AMD development.
• Evaluation of current and emerging therapeutic interventions for AMD.

Main Results:

• AMD pathogenesis involves a complex interplay of genetic factors (e.g., complement pathway mutations), oxidative stress, inflammation, and lipid metabolism.
• Anti-vascular endothelial growth factor (VEGF) therapies have transformed wet AMD management.
• Emerging treatments including gene therapy, complement inhibitors, and stem cell therapies show promise for both wet and dry AMD.

Conclusions:

• Recent insights into AMD pathogenesis provide a foundation for novel therapeutic targets.
• Advancements in treatment offer improved outcomes and future potential for AMD patients.
• Continued research is essential for further optimizing clinical management and exploring new research avenues for AMD.